microRNA Expression Profile in Obesity-Induced Kidney Disease Driven by High-Fat Diet in Mice

Àuria Eritja1, Maite Caus1, Thalia Belmonte2,3

  • 1Vascular and Renal Translational Research Group, Biomedical Research Institute of Lleida Dr. Pifarré Foundation (IRBLleida), 25196 Lleida, Spain.

Nutrients
|March 13, 2024
PubMed

Insights

Obesity causes kidney disease through unclear molecular pathways. This study identified key microRNAs (miRNAs) in mice kidneys affected by high-fat diets, revealing their role in metabolic and inflammatory processes.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Genomics

Background:

  • Obesity is a major risk factor for chronic kidney disease (CKD).
  • The molecular mechanisms underlying obesity-associated nephropathy are not fully understood.
  • MicroRNAs (miRNAs) are implicated in various disease processes, including kidney injury.

Purpose of the Study:

  • To investigate the kidney microRNA (miRNA) expression profile in a mouse model of obesity-induced kidney disease.
  • To identify specific miRNAs involved in the pathophysiology of obesity-associated nephropathy.
  • To explore the potential therapeutic targets for treating obesity-related kidney dysfunction.

Main Methods:

  • Utilized a high-fat diet (HFD) model in C57BL/6J mice to induce obesity and kidney disease.
  • Employed next-generation sequencing (NGS) for comprehensive miRNA expression profiling in kidney tissue.
  • Performed validation analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analyses on differentially expressed miRNAs.

Main Results:

  • HFD induced structural kidney damage, increased pro-inflammatory and pro-fibrotic gene expression, and altered lipid metabolism genes.
  • NGS identified nine differentially expressed miRNAs in the kidneys of HFD mice, with miR-5099, miR-551b-3p, and miR-146a-3p showing significant changes.
  • Validated miRNAs target genes involved in metabolic, adipocytokine, lipid metabolism, inflammatory, senescence, and fibrotic pathways.

Conclusions:

  • Differentially expressed miRNAs play critical roles in the complex mechanisms of obesity-associated kidney disease.
  • These identified miRNAs represent potential novel therapeutic targets for mitigating obesity's detrimental effects on kidney function.
  • Understanding miRNA involvement offers new avenues for developing treatment strategies for nephropathy in obese individuals.